目的:就头颈癌(HNC)患者吞咽困难的管理制定专家共识声明(ECS),以解决争议并提供质量改进的机会。HNC的吞咽困难被定义为患有鼻腔癌症的患者的吞咽障碍,鼻旁窦,鼻咽部,口腔,口咽,喉部,或者下咽.
方法:具有吞咽困难专业知识的开发小组成员遵循既定的ECS开发指南。一位专业的搜索策略师系统地回顾了文献,并利用现有的最佳证据来撰写针对治疗成人HNC人群吞咽困难的提供者的共识声明.开发小组优先考虑了存在重大实践差异的主题,以及如果可能达成共识,将提高HNC患者护理质量的主题。
结果:开发小组确定了60个候选共识声明,根据最初提出的75个主题和问题,重点解决以下高收益主题:(1)风险因素,(2)筛选,(3)评价,(4)预防,(5)干预措施,(六)监督。在德尔菲调查的两次迭代和重复语句的删除之后,48项声明符合共识的标准化定义;12项声明被指定为无共识。
结论:就48项与风险因素有关的陈述达成了专家共识,筛选,评估,预防,干预,和HNC患者吞咽困难的监测。临床医生可以使用这些声明来提高护理质量,告知政策和协议,欣赏没有共识的领域。未来的研究,理想的随机对照试验,有必要解决与HNC患者吞咽困难相关的其他争议。
To develop an expert
consensus statement (ECS) on the management of
dysphagia in head and neck cancer (HNC) patients to address controversies and offer opportunities for quality improvement. Dysphagia in HNC was defined as swallowing impairment in patients with cancers of the nasal cavity, paranasal sinuses, nasopharynx, oral cavity, oropharynx, larynx, or hypopharynx.
Development group members with expertise in
dysphagia followed established
guidelines for developing ECS. A professional search strategist systematically reviewed the literature, and the best available evidence was used to compose consensus statements targeted at providers managing
dysphagia in adult HNC populations. The development group prioritized topics where there was significant practice variation and topics that would improve the quality of HNC patient care if consensus were possible.
The development group identified 60 candidate consensus statements, based on 75 initial proposed topics and questions, that focused on addressing the following high yield topics: (1) risk factors, (2) screening, (3) evaluation, (4) prevention, (5) interventions, and (6) surveillance. After 2 iterations of the Delphi survey and the removal of duplicative statements, 48 statements met the standardized definition for consensus; 12 statements were designated as no
consensus.
Expert consensus was achieved for 48 statements pertaining to risk factors, screening, evaluation, prevention, intervention, and surveillance for
dysphagia in HNC patients. Clinicians can use these statements to improve quality of care, inform policy and protocols, and appreciate areas where there is no consensus. Future research, ideally randomized controlled trials, is warranted to address additional controversies related to dysphagia in HNC patients.